Charbit, H., Mordechai, A., Lossos, A., & Lavon, I. (2018). ANGI-09. CIRCULATING MIR-10B AND MIR-21 IN PATIENTS WITH GBM TREATED WITH BEVACIZUMAB ARE SECRETED TO THE CIRCULATION BY PROTEINS AND THEIR HIGH QUANTIFICATION IS PROBABLY THE RESULT OF DRUG-INDUCED TUMOR HYPOXIA. Neuro Oncol.
Chicago-стиль цитированияCharbit, Hanna, Anat Mordechai, Alexander Lossos, and Iris Lavon. "ANGI-09. CIRCULATING MIR-10B AND MIR-21 IN PATIENTS WITH GBM TREATED WITH BEVACIZUMAB ARE SECRETED TO THE CIRCULATION BY PROTEINS AND THEIR HIGH QUANTIFICATION IS PROBABLY THE RESULT OF DRUG-INDUCED TUMOR HYPOXIA." Neuro Oncol 2018.
MLA-цитированиеCharbit, Hanna, Anat Mordechai, Alexander Lossos, and Iris Lavon. "ANGI-09. CIRCULATING MIR-10B AND MIR-21 IN PATIENTS WITH GBM TREATED WITH BEVACIZUMAB ARE SECRETED TO THE CIRCULATION BY PROTEINS AND THEIR HIGH QUANTIFICATION IS PROBABLY THE RESULT OF DRUG-INDUCED TUMOR HYPOXIA." Neuro Oncol 2018.